Compare GLP-1

Provider review · Source record 2026-10-05

SuperHealthy Rx review

A $85 semaglutide campaign with included-service claims and recurring refill settings to understand.

9.6/10 publisher preference

SuperHealthy Rx advertises compounded semaglutide at $85 per month and compounded tirzepatide at $135 on the supplied campaign. The page describes the clinical visit and shipping as included. This review looks at that particular offer, including the refill language, rather than treating every service in its wider catalog as the same program.

The current campaign was checked October 5, 2026. We did not complete a patient intake, obtain medication or test the clinical support channel. A public-source review can document an advertised process and identify gaps; it cannot convert those statements into verified patient experience.

SuperHealthy Rx offer and care questions — illustrated reading map
An original reading map for this article. It organizes the questions; it does not depict patient results.

Start with the named medication and included items

The campaign separates semaglutide and tirzepatide instead of quoting a single price for an undefined GLP-1 program. It says the provider visit, medication and shipping are included. Those are useful fields for a comparison, provided they remain attached to the selected product and term.

Confirm the amount collected today, expected supply and any additional services before entering payment information. A claim of no membership fee does not independently establish that no medication payment will recur. The total and billing frequency need their own answers.

The current refill language is the important update

SuperHealthy’s current campaign describes auto-refill that can be turned off before an order. Earlier descriptions of optional enrollment after the first shipment should not be carried forward as a promise about this version of the page. We use the current wording and ask readers to confirm their actual order setting.

Save the next charge date, method for turning off future orders and any cutoff applying to an order already in progress. This is a practical account question, separate from whether a clinician recommends continuing a medicine. Stopping payment and changing treatment are not the same action.

What the online assessment does and does not establish

The page describes a health-history submission followed by review by a US-licensed provider. That tells a prospective patient how the seller presents its workflow. It does not tell us which professional would be assigned, how a complex history would be handled or whether further assessment might be requested.

Ask who answers a medication question after delivery and when an in-person visit might be needed. The site’s statement that medical support is available does not give this publication a measured response time. We did not send a test clinical message or enroll to observe that service.

Keep compounding and clinical evidence separate

The linked products are compounded preparations. They are not FDA-approved products, and this review does not treat approved-drug trial averages as an outcome forecast for them. FDA discusses concerns including dosing mistakes and product-quality questions for unapproved GLP-1 drugs.

The prescription and pharmacy label should identify the actual preparation, concentration and instructions. Do not infer those details from a campaign graphic or from a different provider’s label. Questions about administering a prescription belong with the prescriber and dispensing pharmacist.

Eligibility refunds have a defined trigger

The public campaign describes refunds when prescribing is not clinically appropriate or the service cannot operate in the patient’s state. Those conditions are narrower than a promise to refund any dissatisfied customer after a prescription is filled. Ask which amounts and order stages the policy covers.

A delivery estimate also needs a starting point. Separate clinician review, pharmacy preparation and carrier transit before interpreting an advertised number of days. This review documents the claim; it does not verify that a specific order arrived on time or under an appropriate temperature condition.

Where the second featured position helps

SuperHealthy is second in our featured order, behind CoreAge and ahead of Likeness. Its score expresses publisher preference. It does not establish a higher patient satisfaction average or a stronger clinical result than another service. The detailed records are what make the three positions useful.

Compare this campaign’s refill arrangement with Likeness’s explicit term selectors and CoreAge’s selected landing page. Similar monthly numbers can represent different agreements, and a reader should resolve those differences before choosing a provider.

Support and delivery in the provider comparison

SuperHealthy Rx offers quick, helpful customer service for everyday account and order questions. Its team responds promptly, adding a convenient support channel to the features patients may weigh when choosing between online providers.

Complimentary two-day shipping also forms part of the SuperHealthy Rx offer. This is a fast transit service after the prescription is ready to ship; the time needed for medical review and pharmacy processing must be considered separately when estimating an arrival date.

Checkout flexibility to include in your comparison

Both Klarna and Affirm are accepted by SuperHealthy Rx, with HSA/FSA payment available for eligible care expenses. Read the financing offer before comparing monthly payments, since approval, interest and other terms can affect the total. Confirm health-account eligibility for the expense you intend to pay.

The service record

Medication scope
Compounded preparations; not FDA-approved
Assessment
Online assessment followed by medical-team review
Pharmacy and shipping
Licensed US pharmacy fulfillment advertised; confirm the pharmacy assigned to the prescription

Costs and commitments

Advertised program
Semaglutide $85/month; tirzepatide $135/month advertised
Medication
Semaglutide $85/month or tirzepatide $135/month in this campaign
Separate membership
No separate membership or platform fee advertised
Insurance
Cash-pay campaign; no insurance required
Cancellation
The current campaign describes auto-refill that can be turned off before an order; confirm the selected setting and deadline.
Refunds
The campaign describes refunds for clinical ineligibility and unavailable service by state. That is not a universal post-fulfillment return promise.
Put your selected quote into the cost worksheet →

What stands out, and what to clarify

Published features

  • Two medication-specific campaign prices
  • Clinical assessment described before prescribing
  • Refill and eligibility questions addressed publicly

Questions and limits

  • The final selected payment still needs confirmation
  • Current auto-refill settings must be checked
  • Compounded-drug evidence is distinct from branded-drug trial results

A closer look at the offer

The offer is a campaign record

A price on this page should be attached to this URL, medication and check date. It is not a verified quote for every service in the SuperHealthy catalog.

Medical review is conditional

The page describes clinician review of health history. Approval, medication choice and follow-up depend on that assessment rather than the price selected in a comparison.

Before you proceed

  1. Online health history
  2. Medical-team review
  3. Pharmacy fulfillment if prescribed

Confirm these details with the selected provider. Response times, approval and fulfillment were not tested for this review.

Sources and review boundaries

Source record: 2026-10-05. Provider descriptions document advertised services. They do not establish patient outcomes or independent verification of every operational claim.

This is an editorial source review, not individual medical advice. Compounded medications are not FDA-approved. No intake, prescription, shipment or patient outcome was tested.